Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
A network meta-analysis comparing exenatide once weekly with other GLP-1 receptor agonists for the treatment of type 2 diabetes mellitus
Whilst gastrointestinal symptoms such as nausea, vomiting, and diarrhoea are the most commonly reported adverse effects according to the Summary of Product Characteristics (SmPC), some patients report musculoskeletal symptoms, including body aches, although these are not listed among the common side effects in the UK product information
The Swiss pharma said Wednesday morning that its oral GLP-1 Sign up to read this article for free
In addition, there is a U-shaped association between selenium exposure and some diseases, such as type 2 diabetes and fractures [117]
A product page, vial label, or forum protocol is not a substitute for a licensed prescription and patient-specific medical review
Patients should be informed that whilst these symptoms can occur, they often diminish as the body adjusts to the medication, usually within the first few weeks to months of treatment
US$ 26.28
US$ 29.89
US$ 27.81
